Infections caused by Chlamydia spp. are an important cause of human disease, and the accuracy and reproducibility of antimicrobial susceptibility tests for these bacteria could have considerable clinical implications. We have developed a reverse transcriptase PCR (RT-PCR) based method to determine the antibiotic susceptibility of Chlamydia spp., and compared this with conventional tests using immunofluoresence (IF) staining. The MICs of antimicrobial agents for a test strain of Chlamydia pneumoniae were higher by RT-PCR as compared with IF staining, indicating the greater stringency of the former method. Using RT-PCR, doxycycline and tetracycline were the most active agents (MIC 1 mg/L), followed by erythromycin (1.6 mg/L), and ciprofloxacin (16 mg/L). Neither trimethoprim nor sulphamethoxazole (400 mg/L) inhibited growth as assessed by both techniques. The RT-PCR based method may thus represent an improved and less time consuming assay for in-vitro determination of the antibiotic susceptibility of Chlamydia spp.
Introduction
Chlamydia pneumoniae is the third chlamydial species to be recognised (Grayston et al., 1989) , and is an important cause of human respiratory disease (Grayston et al., 1990 . The organism has also been associated with coronary heart disease and myocardial infarction (Saikku et al., 1988; Kuo et al., 1993) . Chemotherapy for C. pneumoniae infections is problematic, partly because of the non-specific nature of symptoms, and difficulties in determining antibiotic susceptibility (Ridgway, 1992) . Improved culture techniques have greatly facilitated isolation procedures. However, the immunofluorescent (IF) test used for antibiotic susceptibility testing involves subjective interpretation of the results, which may explain the discrepancies in published results (Fenelon, Mumtaz & Ridgway, 1990; Cooper et al., 1991) .
The introduction of molecular biology techniques has provided alternative tools for studying bacteria, including determination of viability of the organisms by amplification of the mRNA (Patel, Banerjee & Butcher, 1993) . Initiation of chlamydial growth begins within minutes following the entry of an elementary body into host cells, and this is indicated by the presence of mRNA transcripts (Stephens, 1988) . Thus, the detection of a specific mRNA, encoding a known chlamydial protein, could provide a measure of chlamydial growth and multiplication. We have used this strategy to determine antibiotic susceptibility by the detection of specific mRNA encoding the 75 kDa protein synthesized during growth of chlamydia.
Materials and methods

Antimicrobial agents
Tetracycline hydrochloride was purchased from Sigma Chemical Co. Ltd., Poole, Dorset. Doxycycline hydrochloride (Pfizer, Sandwich, Kent), erythromycin hydrochloride (Abbott Laboratories, Queenborough, Kent), trimethoprim and sulphamethoxazole (Wellcome, Crewe, Cheshire), and ciprofloxacin hydrochloride (Bayer, Newbury, Berks) were kindly donated as pure powders and were solubilized according to the manufacturers' instructions. Solutions were prepared freshly for each experiment.
Test strain
C. pneumoniae IOL-207 was obtained from Dr Linda Cooper, Central Public Health Laboratory (London, England) and passaged in human lung (HL) cells. For sensitivity determination, the inoculum was adjusted by prior titration to yield three to five inclusions per field (x 400 magnification).
MIC determination
The method used for antibiotic susceptibility testing was that described by Cooper et al. (1991) . Briefly, cycloheximide-treated HL cells in trac bottles containing 12 mm diameter glass cover slips (Sterilin) were inoculated with 0.1 mL of the inoculum, and centrifuged at 1200# for 1 h at room temperature. Subsequently, the liquid was replaced with Eagle's Minimum Essential Medium (Life Technologies, Paisley, Scotland) supplemented with non-essential amino acids and 10% v/v fetal calf serum (Life Technologies), and containing serial two-fold dilutions of the antimicrobial agent under test. Three trac bottles were used for each concentration of the antimicrobial agent, in addition to positive (with no antibiotic), and the negative (HL cells with no chlamydia) controls. After incubation for 24 h at 35°C, one bottle for each test concentration and the negative and positive controls (first set) were harvested for RNA extraction, while the cells (second set) were stained using genus-reactive fluorescent monoclonal antibody stain (Central Public Health Laboratory) for the detection of inclusions after a further 48 h incubation. The cellular suspension from the third trac bottle for each antibiotic concentration was inoculated into further two trac bottles in an antibiotic-free medium to determine the MBC. One of the latter preparations was used for an inclusion count and the other used for RNA extraction and RT-PCR detection of DnaK gene mRNA.
RNA extraction
The following precautions were taken to avoid RNA degradation: all glassware was rinsed with distilled water treated with 0.1% v/v diethylpyrocarbonate (DEPC), the chemicals were nucleases-and protein-free, and samples and reaction mixes were kept on ice to minimize the RNase activity. RNA was extracted as described by Yuan et al. (1989) with some modifications. Briefly, after trypsinization, the cells were washed twice in cold (4°C) buffer (0.02 M sodium phosphate and 0.15 M sodium chloride), and then lysed with 1 mL of lysis buffer containing 6 M guanidium chloride and 2 M potassium acetate (19:1 v/v). Following centrifugation at 13,000^ for 10 min at 4°C, the supernatant was transferred into a new eppendorf tube, and mixed with 0.5 mL of cold (-20°C) 95% v/v ethanol. After 4 h at -20°C, the tubes were centrifuged as described above and the pellet dissolved in 1 mL of 25 HIM EDTA, followed by 0.5 mL of 95% ethanol, and the tubes were then left for 2 h at -20°C. This step was repeated for a further cycle of centrifugation, resuspension and precipitation. The pellet was then resuspended in buffer and extracted twice with an equal volume of chloroform :butanol (4:1) for 5 min, followed by centrifugation at 13,000# for 10 min at 4°C to separate the RNA in aqueous phase. Subsequently, two volumes of cold ethanol and 1/5 volume of 3 M sodium acetate were added, and the tubes were left at -20°C overnight to precipitate the RNA, which was then pelleted by centrifugation at 13,000# for 10 min at 4°C. The supernatant was carefully removed, and the pellet was air dried and then taken up in 10 /iL of ultrapure water. The RNA was stored in 70% ethanol at -20°C if not used the same day.
Oligonucleotides
The oligonucleotide PCR primers (20-mer) and probe (22-mer) for the sequence encoding DnaK protein (Kornak, Kuo & Campbell, 1991) were designed and synthesized in the department. The primer sequences used for PCR amplification were selected with the aid of the programme PRIMER, available via the Internet from the SEQNET computing facility of the Daresbury Laboratory (Warrington, England), and amplified a sequence corresponding to bases 836-1250 of the coding region of C. pneumoniae DnaK. The oligonucleotide probe used was an antisense sequence complementary to bases 990-1012 of the coding region of this gene. The probe was selected to recognise an internal sequence of the amplified product such that two additional uridine residues added to the 3' end in the labelling reaction would hybridise with two adenosine residues in the target DNA. The primers and probe are as follows: 
Analysis of RNA for DnaK message by RT-PCR
The RT-PCR was carried out by priming the cDNA synthesis with the specific antisense primer directed at the mRNA of interest. Thus, 1 /iL (100 pmol) of the Z)naA"-specific oligonucleotide primer (K-2) was annealed with 5 /iL of target RNA; 3.5 /iL of ultra pure water and 35 units (1 /iL) of RNAguard (Pharmacia) were also included in the reaction mixture. The mixture was heated to 70°C in a water bath for 10 min and then snap-cooled by plunging into ice for a further 10 min. After a brief centrifugation, the second reaction mix containing 4 /iL of 5 x superscript buffer (0.25 M Tris-HCl, pH 8.3, 0.375 M potassium chloride), 2 /iL of 0.1 M dithiothreitol (DTT), 1 /iL of 20 mM dNTP (Pharmacia), 0.5 /iL (17 units) of RNAguard (Pharmacia), 1 /iL of ultrapure water, and 1 /iL (20 units) of Molony murine leukaemia virus reverse transcriptase (M-MuLV RT: Pharmacia) were added. The preparation was mixed gently, centrifuged briefly to collect the contents, and incubated at 42°C for 2 h. The enzyme was then inactivated by heating at 70°C for 5 min in a water bath, and 10 /iL of 3 M sodium acetate, 50 /iL of 95% cold ethanol, and 1/iL (20 g/L) of nuclease-free glycogen (Boehringer Mannheim) were added and the tubes placed at -20°C for 2 h to allow cDNA to precipitate. After centrifugation at 13,000# for 10 min at 4°C, the supernatant was removed carefully and the pellet washed by adding 50 /iL of 70% cold ethanol. Finally, the cDNA was pelleted and dissolved in 10 /iL of ultrapure water if the PCR was to be carried out the same day, or it was stored in fresh 70% ethanol at -20°C.
PCR was performed using the DnaK primer pair (K-l and K-2) in a total reaction volume of 50/iL. The reaction mix contained 10 mM Tris HC1, pH 8.3, 50 mM KG, 2.5 mM MgCl 2 , 200 g/L of bovine serum albumin, 0.1% Triton X-100, 200 /m each of dATP, dTTP, dCTP and dGTP (DNA polymerase mix, Pharmacia), 100 pmol of each primer and 1 U of Taq DNA polymerase (Appligene, Chester-le-Street, England). The reaction mix was overlaid with 50 /iL of mineral oil and exposed to UV light for 10 min in an Amplirad irradiator (Genetic Research Instrument, Dunmow, England) to inactivate any DNA contamination. Subsequently, 5 /iL of the sample cDNA was added through the mineral oil layer using a positive displacement tip. The samples were subjected to 35 cycles of amplification using a Hybaid Thermal Reactor (Hybaid, Teddington, England), and after an initial 4 min of denaturation at 91°C, each cycle comprised denaturation at 91 C C for 30 s, primer annealing to template at 55°C for 30 s and primer extension at 72°C for 45 s. A final extended elongation at 72°C for 6 min terminated the amplification protocol.
To test the RNA preparations for contamination with chlamydial genomic DNA, each RNA preparation (without conversion to cDNA) was used as template in a parallel PCR reaction using the DnaK primer pair. None of the extract was found positive, thus showing the absence of genomic DNA.
Detection of amplified products
On completion of PCR, the mineral oil layer was removed from each tube. A sample of the aqueous layer containing the amplified product was taken from each reaction tube, mixed with 2/iL of loading buffer (50% v/v glycerol, 0.01% v/v bromophenol blue), and analysed by electrophoresis on a 1.5% w/v agarose gel containing 0.045 M tris-0.045 M borate (pH 8.3)-1 mM EDTA-0.5 mg/L ethidium bromide. The gels were visualized directly by UV transillumination without destaining.
Southern hybridization
The gel was blotted on to Hybond N + nylon membrane (Amersham International, Aylesbury, England) by capillary transfer in 20 x SSC for 18-24 h, and hybridization was performed with DnaK oligonucleotide labelled probe (Enhanced Chemiluminescence 3 oligolabeling kit) and detected using reagents (Amersham International, Aylesbury, England) according to the manufacturer's instructions.
Results
In the RT-PCR reaction described, the DnaK primer pair generated a product of 415 bp from the DNA extracts of C. pneumoniae IOL-207, as predicted from the nucleic acid sequence of the DnaK gene (Kornak et al., 1991) . In addition, these primers were also tested for their ability to amplify DNA extracted from HL cells, used to culture C. pneumoniae; no amplification was detected.
MICs
The MIC results are summarized in the Table. The antimicrobial agents found active against C. pneumoniae included doxycycline, tetracycline, erythromycin, and ciprofloxacin. The MICs of antimicrobial agents varied between the two techniques. In general, the most discrepant results were observed for erythromycin where the MIC was four-fold higher with RT-PCR (Figure 1 ) as compared with IF staining. The MIC of ciprofloxacin (Figure 2) , doxycycline, and tetracycline was two-fold higher by RT-PCR as compared with IF staining, but neither trimethoprim nor sulphamethoxazole inhibited growth at the maximum concentrations (2; 400 mg/L) used (Figure 3 ).
MBCs
The MBCs of erythromycin, ciprofloxacin, and doxycycline as measured by RT-PCR were two-fold higher than those measured by IF staining, but the MBCs of tetracycline were similar for the two methods (Table) .
Discussion
We found that MICs for C. pneumoniae determined by RT-PCR were generally higher compared with those estimated using IF. The most likely explanation for the discrepant results between these techniques is that the antibiotic concentrations that were sufficient to suppress detectable inclusion formation, and therefore to give negative results by IF-staining, were insufficient to cause complete inhibition of multiplication of C. pneumoniae and thus to give negative results by RT-PCR. Thus, high concentrations of antibiotic may allow a low level of bacterial replication without the appearance of The highest tested concentration of each of these antibiotics was 400 mg/L. visible inclusions, or alternatively may alter the appearance of the inclusions such that they may be missed during examination of IF-stained slides. Determination of end points using IF staining and iodine staining is not clear cut; Fenelon et al. (1990) observed apparently intracellular, fluorescent fragments persisting beyond the MIC end point with tetracycline and quinolones, but these bodies bore no morphological resemblance to inclusions. The authors also found that staining with fluorescent antibody, rather than iodine, allowed detection of antigen following exposure of C. trachomatis to high concentrations of antibiotic. Cooper et al. (1991) found reading results particularly difficult for C. pneumoniae as compared with C. trachomatis, while Roblin & Hammerschlag (1990) reported difficulty in breakpoint determination because of changes in the morphology of antibiotic-exposed inclusions, which were also observed in the present study. The use of RT-PCR may thus provide a less subjective alternative to IF staining for estimation of MICs.
We note that our results for MICs determined by IF-staining are in agreement with those observed by Cooper et al. (1991) , and endorse the premise that adding antibiotic agents after infecting the cells mimics the course of disease in vivo. In contrast, studies in which the antibiotic agents were added to the medium before infecting the host cells report MICs by IF-staining which are 4-8 fold lower than we observed (Kuo & Grayston, 1988; Chirgwin, Roblin & Hammerschlag, 1989; Fenelon et al., 1990) .
Determination of MICs using RT-PCR is less subjective than using IF-staining. It should be stressed that precision in carrying out cell culture steps, extraction of undegraded RNA, and avoidance of PCR cross-contamination are essential for obtaining meaningful results with this technique. In addition, the RT-PCR method uses reagents and chemicals which are costly as compared with conventional IF-staining. However, considering the rate of recurrence and morbidity caused by Chlamydia, this extra expense should be judged against the cost of treatment failure. In the present study we used C. pneumoniae IOL-207, which is an established laboratory strain; as interstrain variation with respect to antibiotic susceptibility has been described (Roblin, Montalban & Hammerschlag, 1994) , further studies using clinical isolates are required. There is also a need to extend our findings to C. trachomatis strains, including those with known antibiotic resistance patterns.
